A pooled relative risk with 95% CI was calculated for each intervention comparison group using the Mantel-Haenszel model. Statistical heterogeneity was assessed using the I 2 statistic.
Authors' objectives
To update a previous systematic review (see Other Publications of Related Interest) on the efficacy of antibiotic prophylaxis in reducing wound infections in patients who underwent total joint replacement.
Searching MEDLINE, EMBASE, CINAHL and The Cochrane library were searched. Search terms were reported. Search dates varied across sources and spanned 1966 to July 2007. Google Scholar search engine and AMEDEO Medical Literature Guide were also searched. Reference lists of retrieved articles were handsearched. Primary authors of selected articles were contacted to identify further unpublished clinical trials. Only English-language trials were eligible for inclusion.
Study selection
Randomised controlled trials (RCT) of antibiotics administered preoperatively in any dose and by any route of administration to patients who underwent primary or revision total hip replacement or total knee replacement and which measured wound infection rates were eligible for inclusion. Studies that compared different doses of the same drug were excluded.
Included studies were of the following intervention comparison groups: cephalosporins, lincomycin or penicillin derivatives compared to placebo, no antibiotic cement or no treatment; a variety of systemic antibiotics compared to antibiotic cements; cephalosporins compared to teicoplanin; cephalosporins compared to penicillin derivatives; and first generation cephalosporins compared to second generation cephalosporins. Dosage used and route and timing of administration varied between studies; intravenous administration was the most common route. The duration of treatment ranged from one to 14 days. Included studies were of patients with total hip replacement or total knee replacement. One study was of total joint replacement and other arthroplasties. The definition of wound infection varied between included studies and ranged from early or superficial infection to late or deep infection. The follow-up ranged from 10 days to 10 years. The studies included for review were single and multi-centre trials conducted in North America, Europe and Asia.
The authors stated neither how the studies were selected for the review nor how many reviewers performed the selection.
Assessment of study quality
Validity was assessed using criteria described in the Delphi list measuring randomisation, allocation concealment, blinding, baseline comparability, description of eligibility criteria, sample size, intention-to-treat analysis and excluded data. Methodological quality was assessed by one reviewer.
Data extraction
Data were extracted on the number of wound infections in each group and used to calculate relative risks (RR) with corresponding 95% confidence intervals (CI) for individual studies. Where data were available on the number of joints, these were used rather than the number of patients. When the rates of wound infection in all randomised joints was not available, an available case analysis was used.
